Kenneth J. Hillan - Director at SANGAMO THERAPEUTICS, INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SGMO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kenneth J. Hillan since 24 Dec 2024

Holdings reported by Kenneth J. Hillan for SANGAMO THERAPEUTICS, INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 99.6K $45.8K $0.46 12 Jun 2025 Direct
Stock Option (Right to Buy) 50K 12 Jun 2025 Direct Common Stock

Transactions reported by Kenneth J. Hillan for SANGAMO THERAPEUTICS, INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.